Found: 1
Select item for more details and to access through your institution.
Prognostic factors in patients with metastatic or recurrent pancreatic cancer treated with first-line nab-paclitaxel plus gemcitabine: implication of inflammation-based scores.
- Published in:
- Investigational New Drugs, 2019, v. 37, n. 3, p. 584, doi. 10.1007/s10637-018-0681-y
- By:
- Publication type:
- Article